CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 14:06 UTC

The Annexure

Desk› Healthcare› Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd

BSE 532989 BAFNAPH INE878I01022
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

13 filings · 3 material · busiest 2026-06-22 and 2026-08-11

What it files

Newspaper Publication2 AGM / EGM2 Annual Report1 Book Closure1 Board Outcome1 Results1 Board Meeting1 Compliance Certificate1

Filings

13 in the window

  1. 21 August 2026

    Newspaper Publication

    Newspaper Publication

    We herewith enclose the Newspaper Publication for the 31st Annual General Meeting of the Company published in 'Business Standard' and 'Makkal Kural' on August 20, 2026.

    Company Update / Newspaper Publication View filing →

  2. 19 August 2026

    Annual Report

    Reg. 34 (1) Annual Report.

    We herewith enclose the Annual Report of the Company for the F.Y 2025-2026.

    Others / Reg. 34 (1) Annual Report View filing →

  3. 19 August 2026

    AGM / EGM

    Notice Of 31St Annual General Meeting Of The Company For The F.Y 2025-2026

    We herewith enclose the Notice of 31st Annual General Meeting of the Company scheduled to be held on Friday, September 11, 2026 at 10.00 A.M along with the Annual Report of the Company ....

    AGM/EGM / AGM View filing →

  4. 14 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026 as published in 'Business Standard' and 'Makkal Kural' on August 13, 2026.

    Company Update / Newspaper Publication View filing →

  5. 13 August 2026

    AGM / EGM

    Shareholder Meeting - 31St AGM On September 11, 2026

    We hereby inform that the 31st Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, September 11, 2026 at 10.00 A.M through Video Conferencing (VC) / Other Audio ....

    AGM/EGM / AGM View filing →

  6. 13 August 2026

    Book Closure

    Book Closure For 31St Annual General Meeting

    We herewith enclose the intimation for Book Closure and Cut-Off dates for the purpose of 31st Annual General Meeting of the Company.

    Corp. Action / Book Closure View filing →

  7. 11 August 2026

    Board Outcome

    Board Meeting Outcome for The Board Meeting Held On 11/08/2026

    We hereby inform you that the Board of Directors in their meeting held on August 11, 2026 inter-alia considered and approved i) Unaudited Financial Results of the Company for the Quarter ....

    Board Meeting / Outcome of Board Meeting View filing →

  8. 11 August 2026

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    We herewith enclose the Unaudited Financial Results for the Quarter ended June 30, 2026 as approved by the Board of Directors in its meeting held on August 11, 2026.

    Result / Financial Results View filing →

  9. 5 August 2026

    Board Meeting

    Board Meeting Intimation for Meeting Scheduled On August 11, 2026

    Bafna Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....

    Board Meeting / Board Meeting View filing →

  10. 9 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  11. 26 June 2026

    Trading Window

    Closure of Trading Window

    Intimation for Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  12. 22 June 2026

    Other Update

    Retirement

    Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

    Company Update / Retirement View filing →

  13. 22 June 2026

    Change in Directorate

    Change in Directorate

    Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

    Company Update / Change in Directorate View filing →